Bill 102 inserts a new section into Ontario’s Health Protection and Promotion Act that directs every board of health to ensure colon cancer screening is available to people aged 45 years and older. The provision explicitly references colonoscopies and asserts the duty “despite anything else” in that part of the Act.
The measure shortens the usual screening age threshold currently reflected in many programs, embeds a statutory obligation on local public health authorities, and comes into force three months after Royal Assent. That combination directly affects service capacity, provincial funding needs, and how local health units organize screening pathways.
At a Glance
What It Does
The bill amends the Health Protection and Promotion Act by adding section 5.1, creating a statutory duty for each board of health to ensure colon cancer screening is available to all persons 45 and older and naming colonoscopies as part of that screening. It places this duty above contrary provisions in the same Part.
Who It Affects
Ontario’s local boards of health and public health units must change program planning and funding requests; hospitals and private endoscopy providers will see increased referral volume; provincial health planners and the Ministry of Health must consider capacity and funding; people aged 45–49 constitute a newly prioritized screening cohort.
Why It Matters
The bill converts a policy preference into a legal obligation, which raises immediate operational questions: how to deliver increased screening (faecal immunochemical tests vs direct colonoscopy), who pays for expanded capacity, and how to prevent longer waits for diagnostic and elective procedures.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
Bill 102 is short and focused: it adds a single new provision to Ontario’s Health Protection and Promotion Act that makes boards of health legally responsible for ensuring colon cancer screening is available to everyone aged 45 and older. The text deliberately names colonoscopies as part of the screening services that must be available and contains an overriding clause that applies "despite anything else in this Part," which reduces the potential for conflicting interpretations with existing program rules.
Because the duty is placed on local boards of health rather than on hospitals or the Ministry directly, implementation will fall to public health units to coordinate screening pathways, referral processes, and public communication. The Act does not define what “available” means in practice (for example, whether it requires prompt access within a specific time frame, a guaranteed number of procedures, or active outreach), so boards will have to interpret operational standards while balancing other responsibilities.The bill also creates an immediate timeline pressure: it becomes effective three months after Royal Assent.
That short lead time matters because expanding screening access typically requires funding approvals, scheduling more colonoscopies, training or reallocating staff, and establishing or amplifying FIT-based triage and recall systems. The statutory duty may prompt boards to request additional provincial resources or to reprioritize existing services to meet the new legal obligation without further legislative detail.Finally, the Act does not include funding language, enforcement mechanisms, reporting requirements, or clinical guidance on screening modality and intervals.
Those omissions mean the practical effect will depend on downstream policy and resource decisions by the Ministry of Health, regional hospitals, and boards of health, and on whether clinical guidelines are updated to reflect the lowered age threshold.
The Five Things You Need to Know
The bill adds section 5.1 to the Health Protection and Promotion Act, creating a statutory duty for "every board of health.", It explicitly includes colonoscopies as part of the screening services that must be made available.
The targeted age for eligibility is 45 years and older, effectively lowering the prior commonly used starting age.
The law takes effect three months after Royal Assent, giving a short window before boards must comply.
The text contains an override phrase — "despite anything else in this Part" — that prioritizes the new duty over conflicting provisions in that Part of the Act.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Creates a mandatory access duty on boards of health for colon cancer screening
This is the operative change: the bill inserts a new section requiring every board of health to ensure colon cancer screening is available to individuals 45 and older. Practically, the clause converts policy guidance into a legal obligation at the local public health level. Because the duty is phrased as ensuring availability rather than prescribing specific delivery models, boards retain discretion over whether to expand FIT-based screening, referral pathways to colonoscopy, mobile clinics, or partnerships with private providers — but they must demonstrate availability one way or another.
Places the new duty within the statutory powers and functions framework
By situating the requirement under paragraph 2 of section 5, the bill anchors screening within the existing list of boards' public health responsibilities. That linkage influences how the duty interacts with other statutory obligations (for example, communicable disease control, health promotion). The law’s placement also suggests boards should integrate screening into their regular program planning and budgets rather than treating it as a standalone initiative.
Overrides conflicting provisions in the same Part
The override language reduces legal ambiguity by signaling that the new screening obligation takes precedence over other provisions in that Part of the Act. That could limit defenses based on prior program constraints encoded elsewhere in the statute, but it does not address conflicts arising from regulations, funding agreements, or separate statutes — leaving those disputes to administrative or judicial resolution if they arise.
Three-month delayed proclamation
The Act comes into force three months after Royal Assent. That short, fixed delay forces relatively rapid operational planning: boards will need to assess capacity, identify gaps in equipment and personnel, and seek funding within a compressed timetable. It also gives the Ministry and hospitals a narrow window to issue implementation guidance, if they choose to do so.
Formal short title
The Act’s short title is the Bishop Brigante Colon Cancer Prevention Act, 2026. The title signals the public-health intent of the measure but has no legal effect on implementation or interpretation.
This bill is one of many.
Codify tracks hundreds of bills on this topic across all five countries.
Explore this topic in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- People aged 45–49: Individuals in this younger cohort gain statutory recognition as eligible for screening, which could lead to earlier detection for those at risk.
- Primary care providers and screening program coordinators: Clearer eligibility rules may simplify clinical conversations and referral workflows, enabling more systematic outreach and invitations for screening.
- Cancer survivorship and advocacy groups: Organizations focused on prevention and early detection gain a firm legal basis to push for program expansion and may secure improved case finding and outcomes data.
Who Bears the Cost
- Boards of health (local public health units): They hold the statutory duty and will bear operational burdens — planning, coordination, and possibly reallocating staff or contracting services to meet availability obligations.
- Hospitals and endoscopy services: Increased demand for colonoscopies will strain endoscopy suites, anaesthesia services, pathology, and scheduling systems; hospitals may need to add capacity or alter elective procedure prioritization.
- Provincial government/Ministry of Health: While not named as the implementer, the Ministry will face pressure to fund expanded screening capacity, diagnostics, and follow-up care without a funding clause in the Act.
Key Issues
The Core Tension
The core dilemma pits the public-health benefit of earlier colorectal cancer detection against the reality of constrained diagnostic capacity and funding: the bill legally broadens eligibility to improve outcomes, but doing so without defined standards or guaranteed resources may produce bottlenecks, uneven regional implementation, and trade-offs with other health services.
The bill is brief and leaves critical operational details undefined. It does not specify what "available" means — for instance, whether availability requires timely appointments, a certain number of procedures per capita, or access to FIT testing as a first-line screen.
That vagueness hands considerable discretion to boards of health but also creates legal and political pressure for clear provincial guidance or funding commitments.
Another unresolved issue is capacity. The Act mandates availability "including colonoscopies," but Ontario’s endoscopy capacity varies by region; expanding colonoscopy access without phased implementation risks longer waits for diagnostic procedures or displacement of other elective services.
The statutory override clause strengthens the legal obligation but does not create funding or enforcement mechanisms, so practical compliance will depend on administrative coordination, memoranda of understanding, and possible funding transfers. Finally, absent updated clinical guidelines embedded in the statute, clinicians and program planners will rely on external professional recommendations to set intervals, triage rules, and follow-up protocols — creating potential mismatch between legal eligibility and clinical best practice.
There's more to this law than the bill.
Codify Laws traces every connection across the legislative lifecycle.